missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. TAX1BP1 Antibody (S07-6F6), Novus Biologicals™
  7. 18605693

TAX1BP1 Antibody (S07-6F6), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-19794-50ul

 View more versions of this product

Product Code. 18605693

  • £328.00 / 50µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

TAX1BP1 Monoclonal antibody specifically detects TAX1BP1 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TAX1BP1
Monoclonal
0.3 mg/mL
Western Blot 1:1000, Immunohistochemistry 1:20, Immunohistochemistry-Paraffin
T6BP, Tax1 (human T-cell leukemia virus type I) binding protein 1, tax1-binding protein 1, TRAF6-binding protein, TXBP151CALCOCO3
A synthetic peptide of human TAX1BP1 (Uniprot # Q86VP1)
50 μg
Neuroscience
8887
Store at 4°C short term. Store at -20°C long term. Avoid freeze-thaw cycles.
IgG
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin)
S07-6F6
Unconjugated
50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.05% BSA
Rabbit
Affinity purified
RUO
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.